CRISPR gene editing firm ToolGen boasts of growth potential as its moves to Kosdaq Dec2021.11.26 13: …

crispr gene editing firm toolgen boasts of growth potential as its moves to kosdaq dec2021 11 26 1313

Sumary of CRISPR gene editing firm ToolGen boasts of growth potential as its moves to Kosdaq Dec2021.11.26 13:13:

  • ToolGen CEO Lee Byung-hwa South Korean CRISPR gene-editing company ToolGen Inc. moving to Kosdaq from startup-focused Konex bourse early next month claimed its growth potential was as big as Nasdaq-trading CRISPR stocks.
  • The company is offering 1 million common shares at between 100,000 won ($83.77) and 120,000 won.
  • The company plans to list the new shares on the secondary Kosdaq in early December with an aim to raise a minimum of 100 billion won, which will be used on gene-editing technology research and development projects including facility upgrades.
  • ToolGen is currently listed on the Konex, the country’s third-largest bourse reserved for start-ups and small-to-medium-sized enterprises.
  • [Source: ToolGen Inc.] On Friday, ToolGen shares are trading down 1.4 percent at 140,800 won apiece at Konex, as of 11:23 a.
  • ToolGen is a biotech company specializing in CRISPR gene-editing technology.

Want to know more click here go to source.

From -

Close
Generic selectors
Exact matches only
Search in title
Search in content

Site Language


By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close